Figure 3.
Figure 3. Elimination of RhD-positive RBCs (concentration, mean ± SD) following intravenous administration of either MonoRho at different doses or 1500 IU Rhophylac (300 μg). RhD-positive RBCs (15 mL) were administered 24 hours prior to the anti-RhD injection. The percentage of RBCs remaining in the blood was calculated as for Figure 2.

Elimination of RhD-positive RBCs (concentration, mean ± SD) following intravenous administration of either MonoRho at different doses or 1500 IU Rhophylac (300 μg). RhD-positive RBCs (15 mL) were administered 24 hours prior to the anti-RhD injection. The percentage of RBCs remaining in the blood was calculated as for Figure 2.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal